Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122986) titled 'A Study to Learn About a Vaccine Against E Coli in Healthy Adults' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Double (Participant, Care Provider).
Primary Sponsor: Pfizer
Condition:
Healthy Participants
Intervention:
Drug: E coli vaccine 1 Dose A
Drug: E coli vaccine 1 Dose B
Drug: E coli vaccine 2
Drug: E coli vaccine 3
Drug: E coli Vaccine 4 Dose A
Drug: E coli Vaccine 4 Dose B
Drug: E coli Vaccine 4 Dose C
Drug: E coli Vaccine 5 Dose A
Drug: E coli Vaccine 5 Dose B
Recruitment Status: Not recru...